Propofol Injection, Emulsion
Product Images NDC 51662-1293

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 51662-1293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse Reactions 1 (Adverse Reaction 1)

A table comparing adverse effects of PROPOFOL injection, emulsion 10 mg/mL for Anesthesia/MAC Sedation versus ICU Sedation. It lists cardiovascular, central nervous system, injection site, metabolic/nutritional, respiratory, and skin/appendages effects with specific incidences in pediatric populations when noted.*

FDA Label Image

Adverse Reations 2 (Adverse Reaction 2)

Table listing adverse reactions associated with Propofol injection, emulsion for anesthesia/MAC sedation and ICU sedation. It includes reactions by body system such as anaphylaxis, tachycardia, arrhythmia, agitation, respiratory effects, skin manifestations, and urinary changes.*

FDA Label Image

Adverse Reactions 3 (Adverse Reaction 3)

A table listing adverse reactions of PROPOFOL injection, emulsion, 10 mg/mL, for Anesthesia/MAC Sedation and ICU Sedation. It categorizes reactions by body system, including Body as a Whole, Cardiovascular, Central Nervous System, Digestive, Hematologic/Lymphatic, Injection Site, Metabolic/Nutritional, Respiratory, Skin and Appendages, Special Senses, and Urogenital. Each cell outlines specific adverse events noted for each sedation type.*

FDA Label Image

Clinical Pharma 1 (Clinical Pharma 1)

A line graph depicting plasma propofol concentration (mcg/mL) over time in minutes after the end of infusion. It shows three curves representing recovery after 10 day, 10 hour, and 1 hour infusions, with a horizontal dashed line indicating the target plasma concentration and awakening point.*

FDA Label Image

Clinical Pharma 2 (Clinical Pharma 2)

A table showing age range, induction dose (median and range), and injection duration (median and range) for a drug. The age range listed is birth through 16 years. The induction dose median is 2.5 mg/kg with a range of 1 mg/kg to 3.6 mg/kg. The injection duration median is 20 seconds with a range of 6 seconds to 45 seconds.*

FDA Label Image

Clinical Pharma 3 (Clinical Pharma 3)

A table presenting dosage maintenance and duration data of a drug by age range categories: 2 months to 2 years, 2 to 12 years, and greater than 12 through 16 years. Columns show maintenance dosage in mcg/kg/min with a range, and duration in minutes with ranges in parentheses.*

FDA Label Image

D And A 1 (D And A 1)

A dosing table for Propofol Injectable Emulsion showing rates for primary and secondary agents during different stages: preinduction anxiolysis, induction, and maintenance. It includes opioid dosing rates and titration instructions linked to clinical response, detailing microgram per kilogram per minute and milligram per kilogram dosages for intravenous administration.*

FDA Label Image

D And A 2 (D And A 2)

Dosage and administration instructions for PROPOFOL Injection, Emulsion 10 mg/mL. The text details induction and maintenance dosing for general anesthesia and monitored anesthesia care (MAC) sedation, including dosing adjustments for adults, elderly, cardiac, neurosurgical, pediatric patients, and ICU sedation. It covers infusion rates, bolus doses, and clinical monitoring guidelines.*

FDA Label Image

How Supplied (How Supplied)

Data table presenting units of sale and corresponding NDC codes for a drug product. It shows pack sizes of 5, 20, and 10 cartons paired with 20 mL, 50 mL, and 100 mL Fliptop vials, respectively, alongside their associated NDC numbers.*

FDA Label Image

Indications And Usage (Indications And Usage 1)

A data table listing indications and approved patient populations for PROPOFOL. It includes rows for monitored anesthesia care sedation, combined sedation and regional anesthesia, induction and maintenance of general anesthesia, and ICU sedation of intubated patients, specifying adult or pediatric age groups for each indication.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Label 1293-1 (Serialized Label 1293 1)

PROPOFOL 10 mg/mL injectable emulsion in a 20 mL vial, containing 200 mg of propofol. The label shows it is for single patient use only and contains benzyl alcohol. Distributed by HF Acquisition Co LLC, DBA HealthFirst. The image also includes a barcode and QR code on the adjacent label.*

FDA Label Image

Structure (Structure)

Chemical structure of Propofol showing a benzene ring with hydroxyl group (OH) and two isopropyl groups ((CH3)2CH and CH(CH3)2) attached.*

FDA Label Image

Vial Label (Vial Label)

PROPOFOL injectable emulsion, 10 mg/mL (200 mg/20 mL) in a 20 mL single-use vial. The label highlights that the product contains benzyl alcohol and instructs to shake well before using. Manufactured for Hospira, Inc., Lake Forest, IL. The label includes warnings about microbial growth inhibition and aseptic technique, and details its intravenous administration composition and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.